Le Lézard
Classified in: Health, Business
Subject: PSF

InfoMart Enables Employers to Automatically Track Employee Vaccinations with Expanded Occupational Health Screening Program


MARIETTA, Ga., Jan. 21, 2020 /PRNewswire-PRWeb/ -- InfoMart, a pioneer of the global background screening and identity industry, announces an enhancement to their existing occupational health services: immunization tracking. This enhancement--which rounds out a product suite that includes drug testing, alcohol testing, physicals, and other health services--allows employers and clinical rotations to easily receive, store, track, and manage vaccination and health records. For many industries, vaccination tracking is critical for compliance with internal regulations and mandates outlined by governing agencies.

Companies in unregulated industries may soon follow suit, encouraging a healthy workforce by requiring vaccinations as a condition of employment. Offering a service to automatically track compliance with these requirements not only encourages a fit workforce--it also streamlines this necessary administrative task for HR and recruitment professionals, saving time and money.

InfoMart's immunization solution is particularly advantageous to employers and clinical rotations because it offers unique benefits:

"InfoMart works every single day to expand the menu of solutions we offer to our clients," says Erica Clausen-Lee, InfoMart's Chief Product Officer. "Vaccinations are unique because, while they are necessary for companies in regulated spaces, being able to track inoculation within your workface may become popular across the board in the near future."

"InfoMart works closely with companies in highly regulated industries like healthcare, manufacturing, and staffing," explains Tammy Cohen, Founder and Chief Visionary Officer of InfoMart. "With vaccination tracking, InfoMart delivers every background screening tool necessary for a robust risk mitigation strategy in these industries and others."

To learn more about InfoMart's occupational health services and other background screening solutions, reach out to [email protected] or call (770) 984-2727. For more information about InfoMart or to arrange an interview, please contact [email protected].

About InfoMart
InfoMart has been revolutionizing the global background and identity screening industry for 30 years, providing businesses the information they need to make informed hiring decisions. They develop innovative technology that modernizes talent onboarding, including a first-to-market biometric identity authentication application and a verified sanctions search. The WBENC-certified company is a founding member of the Professional Background Screening Association, and they have achieved PBSA accreditation in recognition of their consistent business practices and commitment to compliance with the FCRA. The company is dedicated to customer service, speed, and accuracy, and it has been recognized for its success, workplace culture, and corporate citizenship with over 45 industry awards. To Get the Whole Story on InfoMart, please visit http://www.InfoMart-USA.com, follow @InfoMartUSA, or call (770) 984-2727.

 

SOURCE InfoMart


These press releases may also interest you

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...



News published on and distributed by: